Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Ethical Considerations in Neurology During the Covid-19 Pandemic Publisher Pubmed



Tabary M1 ; Abolhasani R2 ; Araghi F3 ; Aryannejad A1 ; Safarpour Lima B4, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  4. 4. Department of Neurology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  5. 5. Imam Hossein Medical and Educational Center, Madani St., Tehran, Iran

Source: Neurological Sciences Published:2021


Abstract

Coronavirus disease 2019 (COVID-19) pandemic has struck many countries and caused a great number of infected cases and death. Healthcare system across all countries is dealing with the increasing medical, social, and legal issues caused by the COVID-19 pandemic, and the standards of care are being altered. Admittedly, neurology units have been influenced greatly since the first days, as aggressive policies adopted by many hospitals caused eventual shut down of numerous neurologic wards. Considering these drastic alterations, traditional ethical principles have to be integrated with state-of-the-art ethical considerations. This review will consider different ethical aspects of care in neurologic patients during COVID-19 and how this challenging situation has affected standards of care in these patients. © 2021, Fondazione Societa Italiana di Neurologia.
Other Related Docs
14. Covid-19 Infection and Stroke Risk, Reviews in the Neurosciences (2021)
15. Guillain-Barre Syndrome in a Child Infected With Covid-19, Archives of Pediatric Infectious Diseases (2022)
24. Sars-Cov-2 and Acute Cerebrovascular Events: An Overview, Journal of Clinical Medicine (2021)
28. Covid-19: A Trigger of Autoimmune Diseases, Cell Biology International (2023)